Dedicated to advancing the treatment of liver cancer, TheraSphere is a catheter-based, loco-regional radiation therapy that uses glass microspheres containing radioactive Y90 that are delivered directly to liver tumors via catheter. TheraSphere is the only FDA approved Y-90 treatment for primary liver cancer, expanding access to this life-prolonging therapy for a greater number of patients.
This role is focused on the development and execution of the direct-to-patient strategy for TheraSphere, bringing both awareness as well as education regarding treatment options for patients with primary liver cancer. This Principal Product Manager must be comfortable working in a fast-paced and entrepreneurial environment, demonstrating agility and resilience as we engage patients at scale.
Key responsibilities include:
Required qualifications include:
Preferred qualifications include: